Results 71 to 80 of about 234,365 (193)

Early stage non–small cell lung cancer: Toward a risk‐adaptive paradigm in the era of biologic precision

open access: yesCA: A Cancer Journal for Clinicians, Volume 76, Issue 5, September/October 2026.
Abstract The clinical landscape of early stage non–small cell lung cancer is at transformative crossroads. Driven by the widespread adoption of low‐dose computed tomography screening, the frequent detection of ground‐glass opacities, and a rising incidence among never‐smokers, the diagnostic center of gravity has shifted toward earlier, potentially ...
Chaoqi Zhang   +23 more
wiley   +1 more source

Impact of Surgical Resection on 5‐Year Survival in Elderly NSCLC Patients: A SEER Database Analysis With Machine Learning‐Based Predictive Modeling in Patients Aged ≥ 60 (2000–2021)

open access: yesCancer Medicine, Volume 15, Issue 8, August 2026.
ABSTRACT Background Surgical resection is the primary curative option for elderly patients with non‐small cell lung cancer (NSCLC), but its survival benefit remains debated due to comorbidities and competing risks. This study evaluated the dynamic impact of surgery on long‐term survival and developed machine learning models for prognostic prediction ...
Bo Zhou   +3 more
wiley   +1 more source

Sublobar Resection: Are the Answers Different or Is It the Questions? [PDF]

open access: yesJournal of Thoracic Oncology, 2010
The review by Blasberg et al.1 re-examines the data regarding the role of sublobar resection for non-small cell lung cancer (NSCLC), a question that was “settled” 15 years ago by the Lung Cancer Study Group.2,3 Indeed, they are not alone, as a randomized study re-examining this question is underway by the Cancer and Leukemia Group B oncology group ...
openaire   +1 more source

Athletic Intervention After Thoracic Surgery for Lung Cancer: Rationale and Design of the ATHENA Study

open access: yesHealth Science Reports, Volume 9, Issue 7, July 2026.
ABSTRACT Background The optimal therapeutic approach for early‐stage NSCLC (I–II, and, in some specific cases, IIIa) is lung resective surgery with mediastinal lymphadenectomy. However, it should be remarked that lung resection surgery further negatively affects respiratory muscle function and health‐related quality of life (HRQoL).
Giulia M. Stella   +10 more
wiley   +1 more source

Lobe‐Specific Versus Systematic Lymph Node Dissection in Clinical Stage I Non‐Small Cell Lung Cancer: A Propensity Score‐Matched Analysis Based on the 8th Edition of the TNM Stage Classification

open access: yesThoracic Cancer, Volume 17, Issue 13, July 2026.
In this propensity score‐matched study of clinical stage I non‐small cell lung cancer, lobe‐specific lymph node dissection achieved comparable overall and relapse‐free survival to systematic lymph node dissection while reducing operative invasiveness and postoperative supraventricular tachyarrhythmia.
Hirotsugu Notsuda   +11 more
wiley   +1 more source

Radical sublobar resection for small-sized non–small cell lung cancer: A multicenter study

open access: yes, 2006
ObjectiveAt present, even when early-stage, small-sized non–small cell lung cancers are being increasingly detected, lesser resection has not become the treatment of choice.
Kodama, Ken   +5 more
core   +1 more source

Pulmonary Functional Impact of Resecting Additional Ipsilateral Ground‐Glass Opacities: A Retrospective Propensity Score–Matched Study

open access: yesThoracic Cancer, Volume 17, Issue 13, July 2026.
In patients with multiple ipsilateral ground‐glass opacities, resection of ≥ 2 lesions was associated with lower 1‐year retention of FVC, FEV1, and DLCOc‐SB than resection of a single lesion. Simultaneous resection of additional lesions may involve a functional trade‐off.
Jia Han   +3 more
wiley   +1 more source

Molecular‐Based Risk Prediction Models for Recurrence After Curative Treatment of Early‐Stage Lung Cancer: A Systematic Review and Meta‐Analysis

open access: yesThoracic Cancer, Volume 17, Issue 14, July 2026.
Recurrence occurs in 30%–55% of patients following curative‐intent treatment for early‐stage NSCLC. This systematic review and meta‐analysis evaluated molecular prognostic models for predicting recurrence, identifying five eligible models from 2447 records.
Aaron Ling   +4 more
wiley   +1 more source

O105: Evaluating Surgical Approaches in Non-Small Cell Lung Cancer: Lobectomy vs Sublobar Resection

open access: yes
Background Lung Cancer remains the leading cause of cancer-related mortality, with non-small cell lung cancer (NSCLC) accounting for 85% of cases. Lobectomy has long been regarded as the gold-standard treatment for early-stage NSCLC. A shifting paradigm
Asadi, Nizar   +4 more
core   +1 more source

Postoperative Short-term Outcomes Between Sublobar Resection and Lobectomy in Patients with Lung Adenocarcinoma

open access: yesCancer Management and Research, 2020
Jiaqi Zhang ,* Wenliang Bai ,* Chao Guo, Lei Liu, Guige Wang, Cheng Huang, Yeye Chen, Ye Zhang, Shanqing Li Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College ...
Zhang J   +8 more
doaj  

Home - About - Disclaimer - Privacy